Interaction between asthma and smoking increases the risk of adult airway obstruction

European Respiratory Journal

Volumn 45, Issue 3, 2015, Pages 635-643

  Aanerud, Marianne ^a   Carsin, Anne Elie ^b,c   Sunyer, Jordi ^b,d   Dratva, Julia ^e   Gislason, Thorarinn ^f   Jarvis, Deborah ^g   DeMarco, Roberto ^h   Raherison, Chantal ⁱ   Wjst, Matthias ^j   Dharmage, Shyamali C ^k   Svanes, Cecilie ^a,l  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^f LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF VERONA   (Italy)

ⁱ BORDEAUX UNIVERSITY HOSPITAL   (France)

^j INSTITUTE OF EPIDEMIOLOGY   (Germany)

^k UNIVERSITY OF MELBOURNE   (Australia)

^l UNIVERSITY OF BERGEN   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASTHMA; ATOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; SPIROMETRY; ADVERSE EFFECTS; AGE; AIRWAY OBSTRUCTION; COMPLICATION; EUROPE; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; PSYCHOLOGY; REPRODUCIBILITY; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; AGE FACTORS; AGE OF ONSET; AIRWAY OBSTRUCTION; ASTHMA; EUROPE; FEMALE; HEALTH SURVEYS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 84923868736     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00055514     Document Type: Article

References (43)

1. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1: 1645-1648.
2. James AL, Palmer LJ, Kicic E, et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med 2005; 171: 109-114.
3. Lange P, Parner J, Vestbo J, et al. 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194-1200.
4. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987; 70: 171-179.
5. Silva GE, Sherrill DL, Guerra S, et al. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004; 126: 59-65.
6. Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010; 65: 14-20.
7. Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994; 150: 629-634.
8. Guerra S, Sherrill DL, Kurzius-Spencer M, et al. The course of persistent airflow limitation in subjects with and without asthma. Respir Med 2008; 102: 1473-1482.
9. Lindberg A, Bjerg A, Ronmark E, et al. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006; 100: 264-272.
10. Burrows B, Knudson RJ, Cline MG, et al. A reexamination of risk factors for ventilatory impairment. Am Rev Respir Dis 1988; 138: 829-836.
11. Weiss ST. Atopy and airways responsiveness in chronic obstructive pulmonary disease. N Engl J Med 1987; 317: 1345-1347.
12. Weiss ST. Atopy as a risk factor for chronic obstructive pulmonary disease: epidemiological evidence. Am J Respir Crit Care Med 2000; 162: S134-S136.
13. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-750.
14. Buist AS, Vollmer WM, McBurnie MA. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int J Tuberc Lung Dis 2008; 12: 703-708.
15. Ko FW, Hui DS, Lai CK. Worldwide burden of COPD in high- and low-income countries. Part III. Asia-Pacific studies. Int J Tuberc Lung Dis 2008; 12: 713-717.
16. Menezes AM, Perez-Padilla R, Hallal PC, et al. Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO study. Int J Tuberc Lung Dis 2008; 12: 709-712.
17. Burney PG, Luczynska C, Chinn S, et al. The European Community Respiratory Health Survey. Eur Respir J 1994; 7: 954-960.
18. European Community Respiratory Health Survey II Steering Committee. The European Community Respiratory Health Survey II. Eur Respir J 2002; 20: 1071-1079.
19. Jarvis D, Luczynska C, Chinn S, et al. Change in prevalence of IgE sensitization and mean total IgE with age and cohort. J Allergy Clin Immunol. 2005; 116: 675-682.
20. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998; 88: 15-19.
21. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992; 3: 452-456.
22. Perret JL, Dharmage SC, Matheson MC, et al. The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. Am J Respir Crit Care Med 2013; 187: 42-48.
23. Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349: 1414-1422.
24. Shirtcliffe P, Marsh S, Travers J, et al. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Intern Med J 2012; 42: 83-88.
25. Anto JM, Sunyer J, Basagana X, et al. Risk factors of new-onset asthma in adults: a population-based international cohort study. Allergy 2010; 65: 1021-1030.
26. Haland G, Carlsen KC, Sandvik L, et al. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med 2006; 355: 1682-1689.
27. Edwards CA, Osman LM, Godden DJ, et al. Wheezy bronchitis in childhood: a distinct clinical entity with lifelong significance?. Chest 2003; 124: 18-24.
28. Phelan PD, Robertson CF, Olinsky A. The Melbourne Asthma Study: 1964-1999. J Allergy Clin Immunol 2002; 109: 189-194.
29. Marossy AE, Strachan DP, Rudnicka AR, et al. Childhood chest illness and the rate of decline of adult lung function between ages 35 and 45 years. Am J Respir Crit Care Med 2007; 175: 355-359.
30. Burrows B, Martinez FD. Bronchial responsiveness, atopy, smoking, and chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140: 1515-1517.
31. de Meer G, Kerkhof M, Kromhout H, et al. Interaction of atopy and smoking on respiratory effects of occupational dust exposure: a general population-based study. Environ Health 2004; 3: 6.
32. Sunyer J, Soriano J, Anto JM, et al. Sensitization to individual allergens as risk factors for lower FEV1 in young adults. European Community Respiratory Health Survey. Int J Epidemiol 2000; 29: 125-130.
33. Johannessen A, Omenaas ER, Bakke PS, et al. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005; 60: 842-847.
34. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J 2003; 22: 470-477.
35. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002; 121: 121S-126S.
36. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it?. Thorax 2009; 64: 728-735.
37. Cassino C, Berger KI, Goldring RM, et al. Duration of asthma and physiologic outcomes in elderly nonsmokers. Am J Respir Crit Care Med 2000; 162: 1423-1428.
38. de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One 2013; 8: e62985.
39. Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet 2010; 376: 803-813.
40. Soriano JB, Davis KJ, Coleman B, et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003; 124: 474-481.
41. Postma DS, Boezen HM. Rationale for the Dutch hypothesis. Allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPD. Chest 2004; 126: 96S-104S.
42. Sluiter HJ, Koeter GH, de Monchy JG, et al. The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur Respir J 1991; 4: 479-489.
43. Greenland S. Interactions in epidemiology: relevance, identification, and estimation. Epidemiology 2009; 20: 14-17.